Latest News Archive
Please select Category, Year, and then Month to display items
24 September 2024
|
Story Aimée Barlow
|
Photo Supplied
Louzanne Coetzee, who made history by clinching South Africa’s second medal at the Paralympics, earning a bronze in the T11 1 500 m women’s final with a personal best time, received a warm reception when she recently returned home.
The celebrated Paralympic bronze medallist Louzanne Coetzee returned home to a warm welcome at the Bram Fischer International Airport on 10 September 2024.
Family, friends, colleagues, Arista students, and media gathered to celebrate her remarkable achievement and show their support.
Coetzee – KovsieSport Coordinator of Parasport at the University of the Free State (UFS) – made history by clinching South Africa’s second medal at the Paralympics, earning a bronze in the T11 1 500 m women’s final with a personal best time. Her dedication and hard work have not only brought her personal glory but have also inspired many in her community.
Among those present to welcome her was Jerry Laka, Director of KovsieSport, who expressed his pride in Coetzee’s accomplishments.
"We as KovsieSport are so proud of our colleague Coetzee. It is amazing to see a product of KovsieSport achieving greatness on the world stage. She is truly an inspiration to us all," said Laka.
“I am so glad to be back, and to have Laka and my colleagues here. It means the world to me. Having Laka here shows his commitment to my career and ParaSport and his staff in general,” shared Coetzee, her gratitude evident.
She further expressed her appreciation for the support she received, stating, “I don’t have the words to describe how thankful I am for the support from the UFS community.”
Coetzee’s return is a proud moment for South Africa and the University of the Free State (UFS) community. Welcome home, Louzanne! Your achievements have made us all proud!
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004